LENZ Therapeutics LENZ
NASDAQ LENZ
$3.84 -0.02 (-0.65%)
As of: Sep 30, 2026 · 2:10 PM EDT

LENZ Therapeutics, Inc. (LENZ) Revenue (2025 - 2026)

Updated

LENZ Therapeutics (LENZ) posted Revenue of $5.49 million for Q2 2026, up 9.7% from $5 million a year earlier and up 188.6% from the prior quarter.

Analysis

LENZ Therapeutics, Inc. (LENZ) Revenue (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at LENZ Therapeutics was $21.48 million, up 329.5% year-over-year; for FY2025, it was $19.09 million.

  • Annual Revenue shows a three-year compound annual growth rate of 8.4% (FY2022 to FY2025).
  • In prior years, LENZ Therapeutics' Revenue was $15 million in FY2022.
  • Quarterly Revenue has run from a low of $1.59 million in Q4 2025 to a high of $12.5 million in Q3 2025 over five years.
  • According to Business Quant data, Revenue for the three prior quarters was $1.9 million (Q1 2026), $1.59 million (Q4 2025) and $12.5 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.49 Mn
Mar 31, 2026 1.90 Mn
Dec 31, 2025 1.59 Mn
Sep 30, 2025 12.50 Mn
Jun 30, 2025 5.00 Mn
API Access

LENZ Therapeutics, Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=LENZ&period=max&api_key=YOUR_API_KEY